Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance
Ju Dong Yang¹; Girotra, Mohit¹; Restrepo, Alejandro¹; Waheed, Sarah¹; Barlogie, Bart¹; Duarte Rojo, Andrés^1
1University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, Arkansas. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 461-465]

Hepatocellular adenoma: different entities for a single lesion
Bedossa, Pierre^1
1University Paris-Diderot, Hopital Beaujon, París. Francia
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 450-451]

Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes?
Porres Aguilar, Mateo¹; Gallegos Orozco, Juan Fernando^2
1Texas Tech University, Department of Internal Medicine, El Paso, Texas. Estados Unidos de América; ²University of Utah, School of Medicine, Salt Lake City, Utah. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 468-470]

Long term changes in liver histology following treatment of chronic hepatitis C virus
Shiffman, Mitchell L¹; Sterling, Richard K²; Contos, Melissa²; Hubbard, Sarah²; Long, April¹; Luketic, Velimir A²; Stravitz, R. Todd²; Fuchs, Michael²; Sanyal, Arun J^2
1Bon Secours Health System, Liver Institute of Virginia, Richmond, Virginia. Estados Unidos de América; ²Virginia Commonwealth University, Medical Center, Richmond, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 340-349]

Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma
Pellicelli, Adriano M¹; Vignally, Pascal²; Messina, Vincenzo³; Izzi, Antonio⁴; Mazzoni, Ettore⁵; Barlattani, Angelo⁶; Bacca, Donato⁷; Romano, Mario⁸; Mecenate, Fabrizio⁹; Stroffolini, Tommaso¹⁰; Furlan, Caterina¹⁰; Picardi, Antonio¹¹; Gentilucci, Umberto V¹¹; Gulminetti, Roberto¹²; Bonaventura, Maria E¹³; Villani, Roberto¹; D’Ambrosio, Cecilia¹; Paffetti, Amerigo¹⁰; Mastropietro, Cristina¹⁰; Marignani, Massimo¹⁴; Fondacaro, Lucia¹; Cerasari, Giuseppe¹; Andreoli, Arnaldo¹; Barbarini, Giorgio^12
1Azienda Ospedaliera San Camillo Forlanini, Liver Unit, Roma, Lazio. Italia; ²Instituto Superiore Sanita, Roma, Lazio. Italia; ³Ospedale Sant’Anna, Como. Italia; ⁴Ospedale D. Cotugno, Nápoles, Campania. Italia; ⁵Policlinico Casilino, Roma, Lazio. Italia; ⁶Sistema Sanitario Regionale, Roma, Lazio. Italia; ⁷Ospedale di Casarano, Unita di Hepatologia, Roma, Lazio. Italia; ⁸Ospedale S. Pertini, Unita di Hepatologia, Roma, Lazio. Italia; ⁹Ospedale Santo Spirito, Roma, Lazio. Italia; ¹⁰Policlinico Umberto, Roma, Lazio. Italia; ¹¹Universita "Campus Biomedico", Roma, Lazio. Italia; ¹²Universita di Pavia, Pavia, Lombardia. Italia; ¹³Ospedale San Camillo de Lellis, Rieti. Italia; ¹⁴Azienda Ospedaliera Sant’Andrea, Roma, Lazio. Italia
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 376-385]

Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
Ching-Chung Lin¹; Chia-Hsien Wu¹; Huan-Lin Chen¹; I-Tsung Lin¹; Shen-Yung Wang¹; I-Tsung Lin¹; Shen-Yung Wang¹; Tsang-En Wang¹; Horng-Yuan Wang¹; Shou-Chuan Shih¹; Ming-Jong Bair^1
1Mackay Memorial Hospital, Department of Internal Medicine, Taipei. Taiwán
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 350-355]

Persistent hepatic encephalopathy secondary to portosystemic shunt occluded with Amplatzer device
Ramírez Polo, Ariadna¹; Márquez Guillén, Ernesto¹; González Aguirre, Adrián J²; Casanova Sánchez, Iván E²; Chávez Ruiz, Rafael²; Carrillo Maravilla, Eduardo¹; López Méndez, Eric^1
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Gastroenterología, México, Distrito Federal. México; ²Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Radiología, México, Distrito Federal. México
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 456-460]

Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus. A prospective study
García Compean, Diego¹; Jáquez Quintana, Joel O¹; Lavalle González, Fernando J¹; González González, José A¹; Maldonado Garza, Héctor J¹; Villarreal Pérez, Jesús Z^1
1Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León. México
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 403-410]

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
Ampuero, Javier¹; Campo, José A. del¹; Rojas, Lourdes¹; García Lozano, José R²; Solá, Ricard³; Andrade, Raúl⁴; Pons, José A⁵; Navarro, José M⁶; Calleja, José L⁷; Buti, María⁸; González Escribano, María F²; Forns, Xavier⁹; Diago, Moisés¹⁰; García Samaniego, Javier¹¹; Romero Gómez, Manuel^1
1Hospital Universitario Valme, Unit for Clinical Management of Digestive Diseases and Ciberehd, Sevilla. España; ²Hospital Virgen del Rocío, Unidad de Inmunología, Sevilla. España; ³Hospital del Mar, Barcelona. España; ⁴Hospital Virgen de la Victoria, Unidad de Sistema Digestivo y ciberehd, Málaga. España; ⁵Hospital Universitario Virgen de la Arrixaca, Murcia. España; ⁶Hospital Costa del Sol, Málaga. España; ⁷Hospital Puerta de Hierro, Madrid. España; ⁸Hospital de la Vall d'Hebron, Unidad de Hepatología, Barcelona. España; ⁹Institut d'Investigacions Biomediques August Pi i Sunyer, Unidad de Hígado y Ciberehd, Barcelona. España; ¹⁰Hospital de Valencia, Departamento de Aparato Digestivo, Valencia. España; ¹¹Hospital Carlos III, Unidad de Aparato Digestivo y Ciberehd, Madrid. España
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 356-363]

Predicting outcome in primary biliary cirrhosis
Lammers, Willem J¹; Kowdley, Kris V²; Buuren, Henk R. van^1
1Erasmus University, Medical Center, Rotterdam, Zuid Holland. Países Bajos
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 316-326]

Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis
Lei Jianyong¹; Zhong Jinjing¹; Wang Wentao¹; Yan Lunan¹; Zhou Qiao¹; Li Bo¹; Wen Tianfu¹; Xu Minqing¹; Yang Jiaying¹; Wei Yongang^1
1Sichuan University, West China Hospital, Chengdu, Sichuan. China
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 394-402]

Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin
Kanter, Clara T.M.M. de¹; Luin, Matthijs van¹; Solas, Caroline²; Burger, David M¹; Vrolijk, Jan Maarten^3
1Radboud University, medical center, Nijmegen, Gelderland. Países Bajos; ²Rijnstate Hospital, Department of Gastroenterology and Hepatology, Arnhem. Países Bajos
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 452-455]

Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation
Parvinian, Ahmad¹; Bui, James T¹; Knuttinen, M. Grace¹; Minocha, Jeet¹; Gaba, Ron C^1
1University of Illinois, University Hospital, Chicago, Illinois. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 411-419]

Severe aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome in a patient with non-A-E hepatitis virus infection
Shaaban, Hamid¹; Gauchan, Dron¹; Kahlon, Anmol¹; Maroules, Michael^1
1Seton Hall University, School of Health and Medical Sciences, South Orange, New Jersey. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 466-467]

What is changing in indications and treatment of hepatic hemangiomas. A review
Toro, Adriana¹; Mahfouz, Ahmed-Emad²; Ardiri, Annalisa³; Malaguarnera, Michele⁴; Malaguarnera, Giulia⁵; Loria, Francesco; Bertino, Gaetano⁶; Carlo, Isidoro Di^7
1Ospedale Taormina, Dipartimento di Chirurgia, Messina, Sicilia. Italia; ²Hamad General Hospital, Department of Radiology, Doha City. Qatar; ³Universita di Catania, Department of Medical and Pediatric Science, Catania, Sicilia. Italia; ⁴Universita di Catania, International PhD Program in Neuropharmacology, Catania, Sicilia. Italia; ⁵Ospedale Cannizzaro, Research Center "The Great Senescence", Catania, Sicilia. Italia; ⁶Universita di Catania, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, Catania, Sicilia. Italia; ⁷Hamad Medical Hospital, Department of Surgery, Doha City. Qatar
[Annals of hepatology, México, 2014 Vol. 13 Num. 4 Jul-Ago, Pàg. 327-339]

Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis
Araujo, Alexandre de¹; Silva, Mario Reis Alvares da^1
1Universidade Federal do Rio Grande do Sul, Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul. Brasil
[Annals of hepatology, México, 2014 Vol. 13 Num. 3 May-Jun, Pàg. 390-395]

A modified heterotopic auxiliary living donor liver transplantation: report of a case
Dou, Kefeng¹; Wang, Desheng¹; Tao, Kaishan¹; Yue, Shuqiang¹; Ti. Zhenyu¹; Song, Zhenshun¹; Li, Lin¹; He, Yong¹; Hou, Xiaojuan^1
1The Fourth Military Medical University, Xijing Hospital, Xi’an, Shaanxi. China
[Annals of hepatology, México, 2014 Vol. 13 Num. 3 May-Jun, Pàg. 399-403]

Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats
Licks, Francielli¹; Marques, Camila²; Zetler, Claudio³; Martins, Maria I. Morgan³; Marroni, Claudio A⁴; Marroni, Norma P^4
1Universidade Federal do Rio Grande do Sul, Programa de Pos Graduacao em Ciencias Biologicas, Porto Alegre, Rio Grande do Sul. Brasil; ²Instituto de Tecnologia do Parana, Curitiba, Parana. Brasil; ³Universidade Luterana do Brasil, Canoas, Rio Grande do Sul. Brasil; ⁴Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Rio Grande do Sul. Brasil
[Annals of hepatology, México, 2014 Vol. 13 Num. 3 May-Jun, Pàg. 370-377]

An update on management of Budd-Chiari syndrome
Mancuso, Andrea^1
1Ospedale Niguarda Ca Granda, Epatologia e Gastroenterologia, Milán, Lombardia. Italia
[Annals of hepatology, México, 2014 Vol. 13 Num. 3 May-Jun, Pàg. 323-326]

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
Tabibian, James H¹; Enders, Felicity²; Imam, Mohamad H¹; Kolar, Gururaj¹; Lindor, Keith D³; Talwalkar, Jayant A^1
1Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota. Estados Unidos de América; ²Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, Minnesota. Estados Unidos de América; ³Arizona State University, Executive Vice Provost, Tempe, Arizona. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Num. 3 May-Jun, Pàg. 384-389]